If Ponatinib becomes the best drug in the CML space...and Ariad retains 100%...the multiple for the market cap from here will be breathtaking....113 might be pretty cool also.....DREAMER
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.